Figure 5From: Establishing a Southern Swedish Malignant Melanoma OMICS and biobank clinicalcapabilityResulting mass spectrometry SRM-spectra from lymph node metastasisisolated from MM patients. SRM assay is targeting two peptidesfrom α-synuclein: TVEGAGSIAAATGFVK (left spectrum), andEQVTNVGGAVVTGVTAVAQK (right spectrum).Back to article page